Clinical Trials Browser

Phase 1/2 × Has results × linrodostat × Clear all

NCT03695250 2023-08-22

BMS-986205 and Nivolumab as First or Second Line Therapy in Treating Patients With Liver Cancer

Phase 1/2 Terminated

8 enrolled 11 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT03792750 2022-02-28

A Study of BMS-986205 Alone and in Combination With Nivolumab in Chinese Patients With Advanced Malignant Solid Tumors

Phase 1/2 Completed

12 enrolled 26 charts

Advanced Cancer